Cara Therapeutics
Andrew Albright is an accomplished professional with extensive experience in program and alliance management within the pharmaceutical industry. At Cara Therapeutics, Andrew holds the position of Executive Director for Alliance Management and Chief of Staff, as well as Executive Director of Program Management. Previously, Andrew served as a Senior Director of Program Management in R&D and Director of Project Management at Purdue Pharma, and held project management roles at Pfizer. Andrew possesses a BA in English from the University of New Hampshire and is currently pursuing an MBA in Marketing at Baruch College.
Cara Therapeutics
3 followers
Cara Therapeutics is an early commercial-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs.